Estrella Immunopharma, Inc. (ESLA)
NASDAQ: ESLA · Real-Time Price · USD
0.7600
-0.1673 (-18.04%)
At close: Apr 1, 2025, 4:00 PM
0.8894
+0.1294 (17.03%)
After-hours: Apr 1, 2025, 5:07 PM EDT
Estrella Immunopharma Market Cap
Estrella Immunopharma has a market cap or net worth of $27.49 million as of April 1, 2025. Its market cap has decreased by -27.11% in one year.
Market Cap
27.49M
Enterprise Value
32.72M
1-Year Change
-27.11%
Ranking
Category
Stock Price
$0.76
Market Cap Chart
Since October 19, 2022, Estrella Immunopharma's market cap has increased from $1.78M to $27.49M, an increase of 1,446.23%. That is a compound annual growth rate of 205.88%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 31, 2025 | 33.53M | -22.78% |
| Dec 31, 2024 | 43.41M | 11.11% |
| Dec 29, 2023 | 39.07M | 441.69% |
| Dec 30, 2022 | 7.21M | 305.79% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 741.66B |
| UnitedHealth Group | 479.08B |
| Johnson & Johnson | 399.65B |
| AbbVie | 370.64B |
| Novo Nordisk | 302.16B |
| Abbott Laboratories | 230.06B |
| Merck & Co. | 226.74B |
| AstraZeneca | 225.46B |